Treatment of B-cell malignancies in children with a modified BFM-NHL 90 protocol in argentina
Corresponding Author
Guillermo Chantada MD
Department of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina
Hematología/Oncología Hospital JP Garrahan, Combate de los Pozos 1881, Buenos Aires (C1245AAL), Argentina.Search for more papers by this authorSandra Casak MD
Department of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina
Search for more papers by this authorDaniel Alderete MD
Department of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina
Search for more papers by this authorPedro Zubizarreta MD
Department of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina
Search for more papers by this authorGuillermo Gallo MD
Department of Pathology, Hospital JP Garrahan, Buenos Aires, Argentina
Search for more papers by this authorFederico Sackmann Muriel MD
Department of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina
Search for more papers by this authorCorresponding Author
Guillermo Chantada MD
Department of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina
Hematología/Oncología Hospital JP Garrahan, Combate de los Pozos 1881, Buenos Aires (C1245AAL), Argentina.Search for more papers by this authorSandra Casak MD
Department of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina
Search for more papers by this authorDaniel Alderete MD
Department of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina
Search for more papers by this authorPedro Zubizarreta MD
Department of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina
Search for more papers by this authorGuillermo Gallo MD
Department of Pathology, Hospital JP Garrahan, Buenos Aires, Argentina
Search for more papers by this authorFederico Sackmann Muriel MD
Department of Hematology/Oncology, Hospital JP Garrahan, Buenos Aires, Argentina
Search for more papers by this author
REFERENCES
- 1
Chantada G,
Felice M,
Zubizarreta PA, et al.
Results of a BFM-based for the treatment of childhood B-non-Hodgkin's lymphoma in Argentina.
Med Pediatr Oncol
1997;
28:
333–341.
10.1002/(SICI)1096-911X(199705)28:5<333::AID-MPO2>3.0.CO;2-I CAS PubMed Web of Science® Google Scholar
- 2 Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin Frankfurt Munster Group trial NHL-BFM-90. Blood 1999; 94: 3294–3306.
- 3 Murphy S. Current concepts in cancer. Childhood non-Hodgkin's lymphoma. N Eng J Med 1997; 297: 75–80.
- 4 Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
- 5 Sackmann-Muriel F, Felice M, Zubizarreta P, et al. Treatment results of childhood acute lymphoblastic leukemia with a modified ALL-BFM-90 protocol. Lack of improvement in high-risk group. Leuk Res 1999; 23: 331–340.
- 6 Reiter A, Schrappe M, Parwaresch R, et al. Non Hodgkin's lymphoma of childhood and adolescence. Results of a treatment stratified for biologic subtypes and stage: A report of the BFM group. J Clin Oncol 1995; 13: 359–372.
- 7 Patte C, Philip T, Rodary C, et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Society of Pediatric Oncology of a randomized trial of 216 children. J Clin Oncol 1991; 9: 123–132.
- 8 Reiter A, Schrappe M, Zimmermann M, et al. A 4-hour I.V. infusion of methotrexate 5 g/m2 is not as efficacious for treatment of advanced B-cell neoplasms of childhood and adolescence than 24-hour I.V. infusion although less toxic. Interim result of trial NHL-BFM-95. Blood 2001; 98: 246 (abstract).
